Insider Transactions in Q2 2024 at Maravai Lifesciences Holdings, Inc. (MRVI)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 28
2024
|
Gtcr Investment Xi LLC |
SELL
Open market or private sale
|
Indirect |
9,940,974
-33.04%
|
$89,468,766
$9.81 P/Share
|
|
May 28
2024
|
Gtcr Investment Xi LLC |
BUY
Conversion of derivative security
|
Indirect |
8,409,946
+21.84%
|
-
|
|
May 28
2024
|
Gtcr Investment Xi LLC |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
8,409,946
-7.06%
|
-
|
|
May 23
2024
|
Gregory T Lucier Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,645
+21.41%
|
$206,450
$10.78 P/Share
|
|
May 23
2024
|
Susannah Gray Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,645
+20.36%
|
$206,450
$10.78 P/Share
|
|
May 23
2024
|
John A De Ford Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,645
+28.21%
|
$206,450
$10.78 P/Share
|
|
May 23
2024
|
Luke Joseph Marker Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,645
+29.68%
|
$206,450
$10.78 P/Share
|
|
May 23
2024
|
Jessica Hopfield Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,645
+15.71%
|
$206,450
$10.78 P/Share
|
|
May 23
2024
|
Benjamin James Daverman Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,645
+29.68%
|
$206,450
$10.78 P/Share
|
|
May 23
2024
|
Anat Ashkenazi Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,645
+25.36%
|
$206,450
$10.78 P/Share
|
|
May 23
2024
|
Murali Prahalad Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,645
+23.97%
|
$206,450
$10.78 P/Share
|
|
May 23
2024
|
Sean Laurence Cunningham Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,645
+29.68%
|
$206,450
$10.78 P/Share
|
|
May 23
2024
|
Constantine S Mihas Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,645
+29.68%
|
$206,450
$10.78 P/Share
|
|
Apr 30
2024
|
Peter Michael Leddy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,576
+1.19%
|
$22,880
$5.7 P/Share
|
|
Apr 30
2024
|
Christine Dolan Officer |
BUY
Grant, award, or other acquisition
|
Direct |
483
+0.19%
|
$2,415
$5.7 P/Share
|
|
Apr 30
2024
|
Andrew Burch Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,719
+0.41%
|
$8,595
$5.7 P/Share
|
|
Apr 30
2024
|
Kevin Herde Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,780
+0.53%
|
$8,900
$5.7 P/Share
|
|
Apr 30
2024
|
Kurt Oreshack General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
341
+0.15%
|
$1,705
$5.7 P/Share
|
|
Apr 15
2024
|
Andrew Burch Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,758
-3.84%
|
$134,064
$8.11 P/Share
|